StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Stock Returns for Both Pfizer and AstraZeneca - Essay Example

Cite this document
Summary
The paper "Stock Returns for Both Pfizer and AstraZeneca" utilizes evidence and factual data that Pfizer made four approaches in 2014 terminating the bids in a full and final offer of 55 sterling pounds per share valuing AstraZeneca at 69 billion pounds…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER93.7% of users find it useful
Stock Returns for Both Pfizer and AstraZeneca
Read Text Preview

Extract of sample "Stock Returns for Both Pfizer and AstraZeneca"

AstraZeneca, on the other hand, is a global pharmaceutical company with headquarters in London, in the United Kingdom. It operates in more than 100 countries internationally with a rating as the seventh-largest pharmaceutical firm in terms of sales. AstraZeneca’s revenues value as of 2013 was approximately $ 25, 711 million shillings (Battersby & Grimes 2014, p. 7.36). Compared by the revenues, Pfizer is a larger company than AstraZeneca both the companies being products of the merger.

Nature of Pfizer and AstraZeneca bid process
The current debt to equity ratio at Pfizer is at 0.49, a low and a below-average industrial average. The low figure is an indication of good management of debt levels within the firm. Pfizer had a quick ratio of 2.03 demonstrating its capability to cover and settle short time liquidity needs.

The gross profit of Pfizer during the bidding process span was a high figure of 85.18 percent with its net profit margin accounting at 22.92 percent. The net operating cash flow had a slight increase to $4,087 million, a figure equivalent to 6.71 percent compared to the same quarter one year ago (US. Pharmaceuticals & Healthcare Report 2014, P.15).

Possible Reasons for Changes in Prices on Key dates
Risk and Uncertainty of the takeover
AstraZeneca rejected Pfizer’s final offer on grounds that the takeover may pose a risk to its pharmaceutical operations. In addition, the fear of the uncertainty that could arise led to the collapse of the bid process. It became hard for AstraZeneca to evaluate Pfizer’s final bid given the uncertainty over the total amount that Pfizer could trim off its tax bill by venturing into Britain.

Undervaluation
Pfizer offered a final bid of 69.4 billion sterling pounds, an equivalent amount to $ 117 billion terming the figures full and final. The lack of a proven parameter for evaluating a company with growing and attractive growth prospects led to changes in prices on the final day. Pfizer failed to factor in AstraZeneca’s future prospects in terms of sales and market base.

Political Instability
The concerns on whether Pfizer would eliminate jobs after the merger and diminish Britain’s standing in life sciences indicate the political influence on the deal. The role of every country is to secure job opportunities and strengthen local companies globally. Britain politicians cited Pfizer’s decision in 2011 to shut a facility in Sandwich, England after a merger. The shutting contributed to the loss of more than 1500 jobs that were available raising the unemployment rates to a greater percentage (Great Britain 2013, p.50). In addition, the political risks that Pfizer could use the merger to move its tax domicile to the United Kingdom. The fear of tax inversion by an external corporation led to the changes in price on the final day. Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Examine the stock returns for both Pfizer and AstraZeneca during the Essay”, n.d.)
Examine the stock returns for both Pfizer and AstraZeneca during the Essay. Retrieved from https://studentshare.org/finance-accounting/1666002-examine-the-stock-returns-for-both-pfizer-and-astrazeneca-during-the-bid-process-and-provide-possible-reasons-for-changes-in-price-on-key-dates
(Examine the Stock Returns for Both Pfizer and AstraZeneca During the Essay)
Examine the Stock Returns for Both Pfizer and AstraZeneca During the Essay. https://studentshare.org/finance-accounting/1666002-examine-the-stock-returns-for-both-pfizer-and-astrazeneca-during-the-bid-process-and-provide-possible-reasons-for-changes-in-price-on-key-dates.
“Examine the Stock Returns for Both Pfizer and AstraZeneca During the Essay”, n.d. https://studentshare.org/finance-accounting/1666002-examine-the-stock-returns-for-both-pfizer-and-astrazeneca-during-the-bid-process-and-provide-possible-reasons-for-changes-in-price-on-key-dates.
  • Cited: 0 times

CHECK THESE SAMPLES OF Stock Returns for Both Pfizer and AstraZeneca

Accounting Issues and Solutions in Pharmaceuticals

60 Pages (15000 words) Dissertation

AstraZeneca Marketing Strategy: Challenges and Solutions

Additionally, astrazeneca has been burdened with overcapacity in manufacturing and product development and has been under pressure to downsize and make structural changes (Rosen, 2008).... The challenges faced by astrazeneca also include its slow flow of new products on which it could have further enhanced its growth and also its various attractive patents reaching expiry within the next five years.... Additionally, astrazeneca has been looking for partners and buying out both R and D capabilities as well as expanding its marketing efforts....
46 Pages (11500 words) Essay

Pharmaceutical Companies Listed in London Stock Exchange

Figure 1: Logos by: (Abbott Laboratories, 2011) (astrazeneca, 2007) (BTG, 2011) (Eli Lilly & Co.... 2011) (Johnson & Johnson, 2011) (Merck, 2011) (pfizer, 2011) (SFC-ACS, 2010) (Shire, 2011) (Ventura, 2011) ... f the financial positions of the top pharmaceutical companies listed in London Stock Exchange as well as NYSE, with laser-focused emphasis upon the performances of GlaxoSmithKline (LSE) and pfizer (NYSE).... laxoSmithKline (hereafter referred to as GSK) and pfizer have been close competitors for a long time, although their major focus in terms of type of drug differs substantially, these two companies still compete for top spot within many drug categories....
17 Pages (4250 words) Essay

Pfizer's Unsuccessful Takeover of AstraZeneca

he case in this paper focuses on the failed merger between pfizer and astrazeneca which took place in May, 2014.... The company also questioned transaction structure and offered inversion structure of pfizer and ultimately the proposal ended by the mid of January 2014 (International Business Times, 2014; The Telegraph, 2014; The Guardian, 2014a; 2014b).... It was observed recently that the company tried to acquire astrazeneca but the effort went in vein....
12 Pages (3000 words) Case Study

Pfizers Unsuccessful Takeover of Astrazeneca

his essay describes the example Pfizer's Unsuccessful Takeover of astrazeneca of a failed merger due to the unwillingness of the management to accept the takeover.... On 25th November 2013, Pfizer, a US company expressed its interest to enter into a merger with astrazeneca.... After considering the offer, the astrazeneca rejected the offer and the no more discussion was held after January.... The step of Pfizer to go public on its interest to merge with astrazeneca in April 2014 is an important stage of the merger....
12 Pages (3000 words) Essay

Analysis of Stock Returns for both Pfizer and AstraZeneca during the Bid Process

If investors expect acquisition to Analysis of Stock Returns for Both Pfizer and AstraZeneca during the bid process and possible reasons for change in price on key s Institution: Program:Supervisor:November 14, 2014.... nalysis of Stock Returns for Both Pfizer and AstraZeneca during the bid process and possible reasons for change in price on key datesCommon stock price and return, for a given entity, varies with time and depend on many factors, key to which is investors' perception on expected returns....
2 Pages (500 words) Essay

The Main Rationale for Pfizers Bid

Pfizer is a US domiciled company that launched several unsuccessful bids to acquire astrazeneca that is based in the United Kingdom.... This paper particularly looks at the events surrounding the Pfizer – astrazeneca Merger that was unsuccessful.... Pfizer is a US-domiciled company that launched several unsuccessful bids to acquire astrazeneca that is based in the United Kingdom.... This paper particularly looks at the events surrounding the Pfizer – astrazeneca Merger that was unsuccessful....
13 Pages (3250 words) Coursework

Pfizer Finance and Accounting

pfizer mainly produces and develops vaccines and medicines that are available worldwide.... pfizer was alleged for carrying out illegal marketing of the drug related to arthritis.... The paper "pfizer Finance and Accounting" is a perfect example of a finance and accounting case study.... pfizer is a multinational pharmaceutical company in America.... pfizer mainly produces and develops vaccines and medicines that are available worldwide....
8 Pages (2000 words) Case Study
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us